ANAC: Anacor Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 4,475.42
Book Value ($M) 44.58
Book Value / Share 0.98
Price / Book 100.94
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 6.18
Current Ratio 6.29

Balance Sheet (mrq) ($M)
Current Assets 157.30
Assets 164.00
Liabilities 119.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 82.36
Operating Income -56.38
Net Income n/a
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted -1.39
Earnings Per Share Basic -1.39

Cash Flow Statement (mra) ($M)
Cash From Operations -56.27
Cash from Investing 83.02
Cash from Financing -56.27

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2016-07-11 13G/A Baker Bros. Advisors Lp 0.00 -100.00
2016-07-11 13G/A Fmr Llc 0.00 -100.00
2016-02-16 13G/A Palo Alto Investors LP 4.96 0.00
2016-02-11 13G/A Wellington Management Group Llp 4.75 0.00
2016-02-10 13G Vanguard Group Inc 6.11
2016-01-25 13G/A Eagle Asset Management Inc 2.20
2016-01-08 13G/A BlackRock Inc. 10.00 -0.92
2015-11-06 13D/A Venrock Associates Iv L P 1.80
2015-08-14 13D/A Glaxosmithkline Plc 4.90
2015-02-17 13G/A Kingdon Capital Management, L.l.c. 2.75
2014-03-07 13D/A Aberdare Ventures II, L.P. 2.40
2014-02-14 13D/A Rho Ventures Iv Qp Lp 4.80
2014-02-12 13G/A Price T Rowe Associates Inc /md/ 0.00
2013-11-13 13D/A Rho Ventures Iv Lp 11.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
AMPH – Amphastar Pharmaceuticals, Inc. AMRN – Amarin Corp. Plc
ANAB – AnaptysBio, Inc. ANIP – ANI Pharmaceuticals, Inc.
ANNX – Annexon, Inc.


Financial data and stock pages provided by
Fintel.io